Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference

MARLBOROUGH, Mass., Feb. 27, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Barclays 2015 Annual Healthcare Conference on March 10 in Miami Beach.

Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 25-minute question and answer session regarding the company with the host analyst at approximately 1:05 p.m. ET. Following a 5-minute break, a question and answer session with audience members will begin at approximately 1:35 p.m. ET.

A live webcast of the question and answer session will be available via the Boston Scientific website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Registration at least 15 minutes prior to the scheduled start time is encouraged to ensure a timely connection.

A replay of the webcast will be archived and accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

 

Media:

Investors:

Kelly Leadem

Susie Lisa, CFA

508-683-5543 (office)

508- 683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

kelly.leadem@bsci.com

investor_relations@bsci.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-the-barclays-2015-annual-healthcare-conference-300042457.html

SOURCE Boston Scientific Corporation

Top